Bancel

AHF Salutes Sen. Sanders’ Holding Moderna CEO to Account for Vax Profiteering

Retrieved on: 
Wednesday, March 22, 2023
Philanthropy, Pharmaceutical, Healthcare Reform, Infectious Diseases, Social Activism, Public Policy, Foundation, COVID-19, Communications, AIDS, Congressional News, Views, Health, Government, AHF, Bancel, Vaccination, Capitol Hill, Multimedia, AIDS Healthcare Foundation, United States Senate Health Subcommittee on Children and Families, European Insurance and Occupational Pensions Committee, Mount Independence (Vermont), Education, Pharmaceutical industry

AIDS Healthcare Foundation ( AHF ) issued the following statement in response to congressional hearings being held today on Capitol Hill and chaired by U.S.

Key Points: 
  • AIDS Healthcare Foundation ( AHF ) issued the following statement in response to congressional hearings being held today on Capitol Hill and chaired by U.S.
  • View the full release here: https://www.businesswire.com/news/home/20230321006023/en/
    AHF created this 'Cancel Bancel' artwork for its advocacy work and as protest posters to hold Moderna CEO Stéphane Bancel to account for his and Moderna's pandemic profiteering off the misery caused by COVID-19.
  • “AHF salutes Senator Sanders for holding Moderna CEO Stéphane Bancel to account for profiteering off the misery caused by COVID-19.
  • To learn more about AHF, please visit our website: www.aidshealth.org , find us on Facebook: www.facebook.com/aidshealth and follow us on Twitter: @aidshealthcare and Instagram: @aidshealthcare .

American Institute of Chemical Engineers Celebrates the Extraordinary Societal Contributions of Organizations and Leaders

Retrieved on: 
Thursday, December 2, 2021
Senior, Government, Historically black colleges and universities, American Chemistry Council, STEM, Technology, Industry, Merck, Workforce, Metropolitan Club, Acquisition, Celanese, Company, Student, Chemical engineering, Chemours, Leadership, Education, Futures studies, COVID-19, American, Bancel, ExxonMobil, Research, GLOBE, Organization, RNA, Board, Knowledge, Nanotechnology, Chevron Phillips Chemical, American Institute of Chemical Engineers, Science, RNA transfection, American Institute, Engineering, Partnership, Future, Management, Insurance

A livestream of the gala program was available for those who could not attend the in-person event.

Key Points: 
  • A livestream of the gala program was available for those who could not attend the in-person event.
  • The honor for Moderna was accepted by Stphane Bancel, the companys Chief Executive Officer.
  • At Moderna, we feel a deep sense of responsibility and pride in being part of a solution.
  • AIChE is a professional society of more than 60,000 chemical engineers in 110 countries.

Advocates Step Up ‘Murderna’ VAX Action with Street Theater Protest Thursday (11/18)

Retrieved on: 
Wednesday, November 17, 2021
Infectious Diseases, Public Policy, Government, Philanthropy, AIDS, State, Local, Pharmaceutical, Health, Public Policy, Foundation, Other Policy Issues, MA, Neighbor, News, Government, CEO, AHF, MSNBC, Morning Star, Technology, AIDS Healthcare Foundation, Pfizer, Johnson & Johnson, IPO, Wall Street, AstraZeneca, Korea Disease Control and Prevention Agency, COVID-19, Bancel, The Boston Globe, Twitter, Research, National Directorate for Personal Data Protection, AIDS, Contract, Josh, Organization, RNA transfection, Instagram, Price, Vaccine, VOW, Multimedia, CNN, Element, Center, Advocacy, Facebook, Pharmaceutical industry, Health insurance

Another street theater 'die in' protest takes place THURSDAY, NOVEMBER 18 at 12 noon ET.

Key Points: 
  • Another street theater 'die in' protest takes place THURSDAY, NOVEMBER 18 at 12 noon ET.
  • The protests are part of two weeks of daily weekday actions targeting Moderna in Cambridge.
  • In addition to the protests, a postcard mailer headlined Did You Know Your Neighbor is a Greedy Pandemic Profiteer?
  • Over the summer, AHF spearheaded similar protests targeting Pfizer and Johnson & Johnson at their respective headquarters as fellow egregious pandemic profiteers.

Apollo Intelligence CEO Daniel S. Fitzgerald Named One of the 2021 PM360 Elite 100

Retrieved on: 
Friday, May 14, 2021
Data management, Health, Medical devices, Technology, Practice Management, Research, Science, Medical research, Moderna, Uber, Bancel, Health sciences, Health care, Companies

b'Apollo Intelligence (Apollo), the global insights innovator for the life science industry, announced that its CEO Daniel S. Fitzgerald was named as one of the 2021 PM360 ELITE 100 by PM360 magazine, the premier information resource for marketing decision makers in the pharmaceutical, biotech, diagnostics, and medical device sectors.

Key Points: 
  • b'Apollo Intelligence (Apollo), the global insights innovator for the life science industry, announced that its CEO Daniel S. Fitzgerald was named as one of the 2021 PM360 ELITE 100 by PM360 magazine, the premier information resource for marketing decision makers in the pharmaceutical, biotech, diagnostics, and medical device sectors.
  • By forming Apollo Intelligence, Dan has helped more life science companies leverage the strengths of its two brands\xe2\x80\x94InCrowd and SurveyHealthcareGlobus\xe2\x80\x94capitalizing on their combined value of reach, automation, speed, and expertise.
  • You can read their profiles online at https://www.pm360online.com/the-2021-pm360-elite-100 .\nAdditionally, the 2021 ELITE 100 will be celebrated during a virtual event on June 22nd at 7PM EST.
  • A special keynote address from Uber ELITE Winner St\xc3\xa9phane Bancel, CEO of Moderna, will kick-off the celebration.

PM360 Names Stéphane Bancel, CEO of Moderna, the 2021 Uber ELITE Winner

Retrieved on: 
Monday, May 10, 2021
Medical research, Moderna, Bancel, Health sciences, Health care, Medicine

b'NEW YORK, May 10, 2021 /PRNewswire/ --PM360, the premier information resource for marketing decision makers in the pharmaceutical, biotech, diagnostics, and medical device sectors, today announced that Stphane Bancel, CEO, Moderna is the 2021 Uber ELITE Winner.

Key Points: 
  • b'NEW YORK, May 10, 2021 /PRNewswire/ --PM360, the premier information resource for marketing decision makers in the pharmaceutical, biotech, diagnostics, and medical device sectors, today announced that Stphane Bancel, CEO, Moderna is the 2021 Uber ELITE Winner.
  • The ELITE (Exceptional Leaders Innovators Transformers Entrepreneurs) Awards represent the most influential people in the healthcare and life sciences industries today.
  • And now, because of Stphane and his company, we are on that path.
  • "\nBancel, and the rest of the ELITE 100 winners will be celebrated during a virtual event on June 22nd at 7 PM EST.

TISSIUM Announces Appointment of Independent Board Member

Retrieved on: 
Tuesday, December 15, 2020
Biotechnology, Pharmaceutical, Health, Clinical trials, Medtech, Zimmer Biomet Robotics, Bancel

TISSIUM, a privately-owned medtech company developing biomorphic programmable polymers for tissue reconstruction, announced today that Michel Thrin has been appointed to the Companys Board of Directors.

Key Points: 
  • TISSIUM, a privately-owned medtech company developing biomorphic programmable polymers for tissue reconstruction, announced today that Michel Thrin has been appointed to the Companys Board of Directors.
  • Christophe Bancel, CEO of TISSIUM, said: "We are pleased to have a new member as accomplished and reputable as Michel to join the board at TISSIUM at such a pivotal moment for the company.
  • Mr. Thrin added: I am excited to have the opportunity to work alongside the accomplished innovators at TISSIUM.
  • TISSIUM is a privately-owned medtech company based in Paris, France that is dedicated to the rapid development and commercialization of a unique biopolymer platform to address various unmet clinical needs.

TISSIUM Secures €7M State Guaranteed Loan

Retrieved on: 
Thursday, October 1, 2020
Engineering, Health, Medical devices, Manufacturing, Other Health, Cardiology, Biotechnology, Loans, Financial services, Banking, Medtech, PGE, Bancel, Garanti BBVA, Economy

TISSIUM, a privately-owned medtech company developing biomorphic programmable polymers for tissue reconstruction, announced today it has secured a 7M state-guaranteed loan (Prt Garanti par lEtat, or PGE).

Key Points: 
  • TISSIUM, a privately-owned medtech company developing biomorphic programmable polymers for tissue reconstruction, announced today it has secured a 7M state-guaranteed loan (Prt Garanti par lEtat, or PGE).
  • Initiated by the French Government to support companies during the COVID-19 crisis, the PGE is a bank loan with a fixed interest rate ranging from 0.25% and 1.75%.
  • After an initial interest-only term of one year, the loan can be amortized over up to five years at the option of the Company.
  • Christophe Bancel, CEO of TISSIUM, said, The loan financing that has been awarded TISSIUM as a result of the PGE program will allow us to further extend the runway at TISSIUM and support our ongoing research and development activities.

Moderna Announces First Commercial Organization Outside North America in Switzerland

Retrieved on: 
Wednesday, September 16, 2020
Oncology, Health, Infectious diseases, Other Health, General Health, Biotechnology, Finance, Countries, Articles, Medical research, Vaccines, Moderna, UBS, Bancel, SWITZERLAND

Switzerland is the first country outside of North America to host a Moderna regional hub and commercial organization.

Key Points: 
  • Switzerland is the first country outside of North America to host a Moderna regional hub and commercial organization.
  • I am very excited to have the responsibility for building Modernas first commercial organization outside of North America, said Mr. Staner.
  • Switzerland is a leader in life-sciences, with a dynamic pool of industry talent, scientists, research organizations, investors and global health policymakers, said Stphane Bancel, CEO of Moderna.
  • Opening our first subsidiary outside North America in Switzerland is a natural step for Moderna.

Indigo Ag Announces an Additional $360M in Financing, Appoints Stéphane Bancel, Moderna CEO, to Board of Directors

Retrieved on: 
Monday, August 3, 2020
Agriculture, Natural Resources, Branches of biology, Life sciences, Biotechnology, Moderna, Messenger RNA, Bancel

Indigo Agriculture, a company dedicated to harnessing nature to help farmers sustainably feed the planet, announces the closing of $360M in additional financing.

Key Points: 
  • Indigo Agriculture, a company dedicated to harnessing nature to help farmers sustainably feed the planet, announces the closing of $360M in additional financing.
  • Combined with $175M in convertible equity announced in January 2020, this brings the companys total Series F preferred financing to $535M.
  • Also announced today is the appointment of Stphane Bancel, Founding CEO of Moderna Inc. (NASDAQ: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, to the Board of Directors.
  • Bancel has served as the CEO of Moderna since October 2011 and as a member of Modernas board of directors since March 2011.